Difference between revisions of "Template:Acetylcholine receptor modulators"

From blackwiki
Jump to navigation Jump to search
blackwiki>Medgirl131
blackwiki>Medgirl131
Line 4: Line 4:
 
  | state = {{{state<includeonly>|collapsed</includeonly>}}}
 
  | state = {{{state<includeonly>|collapsed</includeonly>}}}
 
  | listclass = hlist
 
  | listclass = hlist
 
 
  | selected = {{{selected|{{{1|}}}}}}
 
  | selected = {{{selected|{{{1|}}}}}}
 +
| groupstyle = text-align:center;
  
  | section1 = [[Acetylcholine receptor|Receptor]] [[ligand]]s
+
  | section1 = [[Acetylcholine receptor|Receptor]] [[receptor modulator|modulator]]s
 
  | abbr1 = Receptor
 
  | abbr1 = Receptor
 
  | state1 = uncollapsed
 
  | state1 = uncollapsed
 
  | list1 = {{Navbox|child
 
  | list1 = {{Navbox|child
 +
| groupstyle = text-align:center;
  
 
   | group1 = [[Muscarinic acetylcholine receptor|mACh]]
 
   | group1 = [[Muscarinic acetylcholine receptor|mACh]]
 
   | list1 =
 
   | list1 =
* '''[[Muscarinic agonists]]:''' [[77-LH-28-1]]
+
* '''Agonists:''' [[77-LH-28-1]]
 
* [[AC-42]]
 
* [[AC-42]]
 
* [[AC-260,584]]
 
* [[AC-260,584]]
Line 69: Line 70:
 
* [[YM-796]]
 
* [[YM-796]]
  
* '''[[Muscarinic antagonists]]:''' [[3-Quinuclidinyl benzilate]]
+
* '''Antagonists:''' [[3-Quinuclidinyl benzilate]]
 
* [[1,1-Dimethyl-4-diphenylacetoxypiperidinium iodide|4-DAMP]]
 
* [[1,1-Dimethyl-4-diphenylacetoxypiperidinium iodide|4-DAMP]]
 
* [[Aclidinium bromide]]
 
* [[Aclidinium bromide]]
Line 163: Line 164:
 
   | group2 = [[Nicotinic acetylcholine receptor|nACh]]
 
   | group2 = [[Nicotinic acetylcholine receptor|nACh]]
 
   | list2 =
 
   | list2 =
* '''[[Nicotinic agonists]]:''' [[5-Hydroxyindoleacetic acid|5-HIAA]]
+
* '''Agonists:''' [[5-Hydroxyindoleacetic acid|5-HIAA]]
 
* [[A-84,543]]
 
* [[A-84,543]]
 
* [[A-366,833]]
 
* [[A-366,833]]
Line 232: Line 233:
 
* [[XY-4083]]
 
* [[XY-4083]]
  
* '''[[Nicotinic antagonists]]:''' [[18-Methylaminocoronaridine|18-MAC]]
+
* '''Antagonists:''' [[18-Methylaminocoronaridine|18-MAC]]
 
* [[18-Methoxycoronaridine|18-MC]]
 
* [[18-Methoxycoronaridine|18-MC]]
 
* [[α-Neurotoxin]]s (e.g., [[α-bungarotoxin]], [[α-cobratoxin]], [[α-conotoxin]], many others)
 
* [[α-Neurotoxin]]s (e.g., [[α-bungarotoxin]], [[α-cobratoxin]], [[α-conotoxin]], many others)
Line 321: Line 322:
 
  }}
 
  }}
  
  | section2 = [[Neurotransmitter transporter|Transporter]] [[Ligand (biochemistry)|ligands]]
+
  | section2 = [[Neurotransmitter transporter|Transporter]] [[transporter modulator|modulator]]s
 
  | abbr2 = Transporter
 
  | abbr2 = Transporter
 
  | state2 = uncollapsed
 
  | state2 = uncollapsed
 
  | list2 = {{Navbox|child
 
  | list2 = {{Navbox|child
 +
| groupstyle = text-align:center;
  
 
   | group1 = [[Choline transporter|CHT]]
 
   | group1 = [[Choline transporter|CHT]]
Line 330: Line 332:
 
* '''Inhibitors:''' [[Hemicholinium-3|Hemicholinium-3 (hemicholine)]]
 
* '''Inhibitors:''' [[Hemicholinium-3|Hemicholinium-3 (hemicholine)]]
 
* [[Triethylcholine]]
 
* [[Triethylcholine]]
 +
 
* '''Enhancers:''' [[Coluracetam]]
 
* '''Enhancers:''' [[Coluracetam]]
  
Line 342: Line 345:
 
  | state3 = uncollapsed
 
  | state3 = uncollapsed
 
  | list3 = {{Navbox|child
 
  | list3 = {{Navbox|child
 +
| groupstyle = text-align:center;
  
 
   | group1 = [[Choline acetyltransferase|ChAT]]
 
   | group1 = [[Choline acetyltransferase|ChAT]]
Line 473: Line 477:
 
* [[Fasciculin|Fasciculins (green mamba toxins)]] ([[Fasciculin 1|1]], [[Fasciculin 2|2]], [[Fasciculin 3|3]], [[Fasciculin 4|4]])
 
* [[Fasciculin|Fasciculins (green mamba toxins)]] ([[Fasciculin 1|1]], [[Fasciculin 2|2]], [[Fasciculin 3|3]], [[Fasciculin 4|4]])
 
* [[Onchidal]] (''[[Onchidella binneyi]]'')
 
* [[Onchidal]] (''[[Onchidella binneyi]]'')
 +
 
* '''Reactivators:''' [[Asoxime]]
 
* '''Reactivators:''' [[Asoxime]]
 
* [[Obidoxime]]
 
* [[Obidoxime]]
Line 488: Line 493:
 
  | state4 = uncollapsed
 
  | state4 = uncollapsed
 
  | list4 = {{Navbox|child
 
  | list4 = {{Navbox|child
 +
| groupstyle = text-align:center;
  
 
   | group1 = [[Release inhibitor|Inhibitors]]
 
   | group1 = [[Release inhibitor|Inhibitors]]
Line 507: Line 513:
 
  | state5 = uncollapsed
 
  | state5 = uncollapsed
 
  | list5 = {{Navbox|child
 
  | list5 = {{Navbox|child
 +
| groupstyle = text-align:center;
  
 
   | group1 = [[Precursor (chemistry)|Precursors]] /<br />[[prodrug]]s
 
   | group1 = [[Precursor (chemistry)|Precursors]] /<br />[[prodrug]]s

Revision as of 14:53, 29 April 2017

50px Template documentation

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Acetylcholine receptor modulators|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Acetylcholine receptor modulators|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Acetylcholine receptor modulators|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.

How to manage this template's collapsible groups/sections option
  • This template includes collapsible groups/sections. When it first appears, one of these groups/sections may be set to be visible ("expanded") while the others remain hidden ("collapsed") apart from their titlebars. To achieve this, include the parameter |name where name is one of the following words that identify the groups/sections (omit any speech or quotation marks):
    • Receptor
    • Transporter
    • Inhibitors
    • Others
  • For example: {{Acetylcholine receptor modulators |Receptor}}
sr:Шаблон:Холинергици